BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17241316)

  • 1. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry.
    Gilliam FR; Kaplan AJ; Black J; Chase KJ; Mullin CM
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):56-64. PubMed ID: 17241316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure.
    Fantoni C; Raffa S; Regoli F; Giraldi F; La Rovere MT; Prentice J; Pastori F; Fratini S; Salerno-Uriarte JA; Klein HU; Auricchio A
    J Am Coll Cardiol; 2005 Nov; 46(10):1875-82. PubMed ID: 16286175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of heart rate variability footprint and standard deviation of average 5-minute intrinsic R-R intervals for mortality in cardiac resynchronization therapy patients.
    Gilliam FR; Singh JP; Mullin CM; McGuire M; Chase KJ
    J Electrocardiol; 2007 Oct; 40(4):336-42. PubMed ID: 17320897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): design and rationale.
    Martin DO; Stolen KQ; Brown S; Yu Y; Christie C; Doshi SK; Smith JM; Gold MR; Day JD
    Am Heart J; 2007 Jan; 153(1):7-13. PubMed ID: 17174627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device.
    Adamson PB; Smith AL; Abraham WT; Kleckner KJ; Stadler RW; Shih A; Rhodes MM;
    Circulation; 2004 Oct; 110(16):2389-94. PubMed ID: 15313946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure.
    León AR; Abraham WT; Brozena S; Daubert JP; Fisher WG; Gurley JC; Liang CS; Wong G;
    J Am Coll Cardiol; 2005 Dec; 46(12):2298-304. PubMed ID: 16360062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
    Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
    J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
    Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
    J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy.
    Singh JP; Rosenthal LS; Hranitzky PM; Berg KC; Mullin CM; Thackeray L; Kaplan A
    Europace; 2009 Dec; 11(12):1647-53. PubMed ID: 19752011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): a reliable and safe approach.
    Gasparini M; Galimberti P; Regoli F; Ceriotti C; Bonadies M
    J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1279-83. PubMed ID: 16403056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.